Dr Talha Munir is a Consultant Haematologist at Leeds Teaching Hospitals National Health Service (NHS) Trust, Leeds, UK. He graduated from King Edward Medical College, Lahore, Pakistan, in 2002, and finished his initial training in Pakistan. He has worked in the NHS since 2004, and completed his haematology training in Nottingham, UK, in 2012. Along with his clinical commitments, Dr Munir is currently in the process of finishing his PhD in the area of chronic lymphocytic leukaemia (CLL) at the Leeds Institute of Cancer and Pathology.
His main clinical and research interests are in CLL, particularly in the assessment of the mechanism of action of novel targeted therapies. His other clinical interests include the management of patients with aplastic anaemia and paroxysmal nocturnal haemoglobinuria (PNH), and he is one of the PNH consultants working in the PNH National Service. He also has a special interest in the management of adult histiocytic disorders, especially Langerhans’ cell histiocytosis and Erdheim–Chester disease.
Dr Munir is a sub-investigator for the National Cancer Research Institute (NCRI) CLL Phase II and III clinical trials in the UK, and is involved in multiple NCRI and non-NCRI studies at Leeds Teaching Hospitals, where he has contributed to the development of an impressive trial portfolio.
EM-95600 - Date of preparation: April 2022